Jonathan Mink
Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Movement Disorders | 9 | 1995 | 32 |
Why?
|
Basal Ganglia | 14 | 1991 | 23 |
Why?
|
Tourette Syndrome | 9 | 2000 | 11 |
Why?
|
Deep Brain Stimulation | 11 | 2004 | 8 |
Why?
|
Dystonia | 11 | 1995 | 7 |
Why?
|
Globus Pallidus | 8 | 1987 | 5 |
Why?
|
Cerebral Palsy | 5 | 2000 | 17 |
Why?
|
Subthalamic Nucleus | 6 | 2003 | 2 |
Why?
|
Movement | 8 | 1986 | 69 |
Why?
|
Parkinson Disease | 11 | 2001 | 67 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 5 | 2005 | 13 |
Why?
|
Neural Inhibition | 4 | 1996 | 30 |
Why?
|
Levodopa | 5 | 2000 | 28 |
Why?
|
Dopamine | 5 | 2000 | 62 |
Why?
|
Essential Tremor | 6 | 2000 | 1 |
Why?
|
Motor Skills | 5 | 1987 | 28 |
Why?
|
Child | 23 | 1998 | 749 |
Why?
|
Thalamus | 5 | 2001 | 23 |
Why?
|
Humans | 70 | 1980 | 1856 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2002 | 29 |
Why?
|
Electric Stimulation Therapy | 6 | 2000 | 16 |
Why?
|
Tic Disorders | 2 | 2002 | 7 |
Why?
|
Chorea | 4 | 2003 | 5 |
Why?
|
Mental Disorders | 5 | 2005 | 132 |
Why?
|
Brain | 8 | 1981 | 305 |
Why?
|
Mood Disorders | 2 | 2002 | 31 |
Why?
|
Psychomotor Performance | 3 | 1987 | 69 |
Why?
|
Molecular Chaperones | 2 | 2005 | 30 |
Why?
|
Masturbation | 2 | 1995 | 4 |
Why?
|
Tics | 4 | 2001 | 4 |
Why?
|
Antiparkinson Agents | 2 | 2000 | 23 |
Why?
|
Stereotypic Movement Disorder | 1 | 2010 | 1 |
Why?
|
Dyskinesias | 1 | 2010 | 7 |
Why?
|
Task Performance and Analysis | 5 | 1991 | 25 |
Why?
|
Motor Cortex | 1 | 2011 | 13 |
Why?
|
Anticonvulsants | 2 | 1999 | 61 |
Why?
|
Intralaminar Thalamic Nuclei | 1 | 2009 | 1 |
Why?
|
Piracetam | 1 | 2009 | 3 |
Why?
|
Male | 40 | 1980 | 1553 |
Why?
|
Streptococcal Infections | 2 | 2005 | 54 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 154 |
Why?
|
Adolescent | 15 | 1980 | 891 |
Why?
|
Myoclonus | 2 | 2003 | 6 |
Why?
|
Dihydroxyphenylalanine | 3 | 2001 | 12 |
Why?
|
Neuropsychological Tests | 2 | 2005 | 113 |
Why?
|
Neural Pathways | 3 | 2002 | 48 |
Why?
|
Apraxias | 2 | 2006 | 3 |
Why?
|
Dystonic Disorders | 2 | 2004 | 1 |
Why?
|
Motor Neurons | 2 | 1996 | 45 |
Why?
|
Female | 34 | 1980 | 1643 |
Why?
|
Phenotype | 2 | 2005 | 303 |
Why?
|
Psychomotor Disorders | 1 | 2007 | 18 |
Why?
|
Health Planning Guidelines | 1 | 2006 | 19 |
Why?
|
Magnetic Resonance Imaging | 5 | 1999 | 294 |
Why?
|
Dopamine Agents | 2 | 2000 | 19 |
Why?
|
Neurobiology | 1 | 2006 | 4 |
Why?
|
Ventral Thalamic Nuclei | 4 | 2000 | 2 |
Why?
|
Brain Diseases | 1 | 2006 | 75 |
Why?
|
Spinal Cord | 1 | 2006 | 94 |
Why?
|
Patient Selection | 1 | 2006 | 155 |
Why?
|
Muscles | 5 | 1980 | 111 |
Why?
|
Severity of Illness Index | 8 | 2000 | 358 |
Why?
|
Cerebral Cortex | 2 | 2003 | 108 |
Why?
|
Receptors, Dopamine | 1 | 2004 | 16 |
Why?
|
Ganglioglioma | 1 | 2003 | 6 |
Why?
|
Biomechanics | 4 | 1999 | 79 |
Why?
|
Motor Activity | 4 | 1983 | 104 |
Why?
|
Cerebellar Neoplasms | 1 | 2003 | 16 |
Why?
|
Evidence-Based Medicine | 1 | 2004 | 125 |
Why?
|
Child, Preschool | 8 | 1995 | 554 |
Why?
|
Cephalometry | 1 | 2002 | 24 |
Why?
|
Muscimol | 2 | 1991 | 8 |
Why?
|
Pantothenate Kinase-Associated Neurodegeneration | 1 | 2001 | 3 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 174 |
Why?
|
Treatment Outcome | 10 | 2000 | 661 |
Why?
|
Handwriting | 1 | 2001 | 2 |
Why?
|
Autistic Disorder | 1 | 2002 | 24 |
Why?
|
Carbidopa | 1 | 2000 | 10 |
Why?
|
Quadriplegia | 1 | 2000 | 12 |
Why?
|
Hand Strength | 1 | 1999 | 18 |
Why?
|
Nerve Net | 3 | 2001 | 23 |
Why?
|
Brain Mapping | 4 | 1998 | 61 |
Why?
|
Basal Ganglia Diseases | 1 | 1998 | 14 |
Why?
|
Animals | 19 | 1981 | 1031 |
Why?
|
Electromyography | 8 | 1986 | 55 |
Why?
|
Neurons | 8 | 1983 | 195 |
Why?
|
Biomedical Research | 2 | 2008 | 87 |
Why?
|
Muscle Hypertonia | 2 | 2003 | 2 |
Why?
|
Middle Aged | 17 | 1980 | 1161 |
Why?
|
Questionnaires | 3 | 2002 | 360 |
Why?
|
Wrist | 4 | 1987 | 27 |
Why?
|
Gait | 4 | 1998 | 16 |
Why?
|
Diagnosis, Differential | 5 | 1995 | 402 |
Why?
|
Adult | 13 | 1980 | 1317 |
Why?
|
Aged | 15 | 1980 | 988 |
Why?
|
Young Adult | 2 | 2010 | 380 |
Why?
|
Neurologic Examination | 3 | 1995 | 64 |
Why?
|
Behavior, Animal | 4 | 1981 | 77 |
Why?
|
Combined Modality Therapy | 2 | 2003 | 219 |
Why?
|
Macaca mulatta | 5 | 1987 | 71 |
Why?
|
Corpus Striatum | 2 | 2005 | 48 |
Why?
|
Positron-Emission Tomography | 4 | 2004 | 32 |
Why?
|
Muscle Rigidity | 3 | 2003 | 4 |
Why?
|
Behavior | 1 | 1993 | 36 |
Why?
|
Tremor | 2 | 2002 | 14 |
Why?
|
Stereotaxic Techniques | 2 | 2000 | 24 |
Why?
|
Tomography, Emission-Computed | 4 | 2001 | 25 |
Why?
|
Muscle Contraction | 2 | 1991 | 77 |
Why?
|
Functional Laterality | 2 | 2008 | 50 |
Why?
|
Metabolism, Inborn Errors | 1 | 2010 | 9 |
Why?
|
Hyperkinesis | 1 | 2010 | 5 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2010 | 11 |
Why?
|
Hypokinesia | 2 | 2002 | 1 |
Why?
|
Disease Progression | 4 | 2003 | 244 |
Why?
|
Drug Therapy | 1 | 2010 | 38 |
Why?
|
Infant | 3 | 2003 | 464 |
Why?
|
Drug Therapy, Combination | 2 | 2000 | 189 |
Why?
|
Homozygote | 1 | 2010 | 68 |
Why?
|
Sex Distribution | 1 | 2010 | 101 |
Why?
|
Heterozygote | 1 | 2010 | 80 |
Why?
|
Central Nervous System | 1 | 2010 | 77 |
Why?
|
Age Distribution | 1 | 2010 | 127 |
Why?
|
Models, Neurological | 2 | 1998 | 59 |
Why?
|
Sequence Deletion | 1 | 2010 | 88 |
Why?
|
Obsessive-Compulsive Disorder | 2 | 2006 | 19 |
Why?
|
Cerebrovascular Circulation | 3 | 2002 | 62 |
Why?
|
Behavior Therapy | 1 | 2010 | 51 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2010 | 52 |
Why?
|
Prognosis | 2 | 2005 | 388 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2010 | 99 |
Why?
|
Arm | 1 | 2009 | 48 |
Why?
|
Neurology | 2 | 2006 | 28 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2007 | 7 |
Why?
|
Trihexyphenidyl | 1 | 2007 | 2 |
Why?
|
Intraoperative Care | 1 | 2007 | 34 |
Why?
|
Reaction Time | 3 | 1991 | 81 |
Why?
|
Muscarinic Antagonists | 1 | 2007 | 10 |
Why?
|
Incidence | 1 | 2010 | 336 |
Why?
|
Genetic Linkage | 1 | 2007 | 57 |
Why?
|
Recurrence | 2 | 1999 | 261 |
Why?
|
Muscular Dystrophies | 1 | 2008 | 28 |
Why?
|
Memory, Short-Term | 1 | 2007 | 13 |
Why?
|
Motor Skills Disorders | 1 | 2006 | 5 |
Why?
|
Dystonia Musculorum Deformans | 1 | 2006 | 4 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 11 |
Why?
|
Muscle Proteins | 1 | 2007 | 56 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 178 |
Why?
|
Developmental Disabilities | 1 | 2007 | 54 |
Why?
|
Gene Therapy | 1 | 2008 | 89 |
Why?
|
Attention | 1 | 2007 | 64 |
Why?
|
Personality Tests | 1 | 2005 | 16 |
Why?
|
Electric Stimulation | 1 | 2006 | 101 |
Why?
|
Azithromycin | 1 | 2005 | 13 |
Why?
|
Longitudinal Studies | 1 | 2007 | 195 |
Why?
|
Organ Size | 1 | 2006 | 118 |
Why?
|
Regional Blood Flow | 1 | 2006 | 105 |
Why?
|
Pediatrics | 1 | 2010 | 133 |
Why?
|
Autoantibodies | 2 | 1980 | 64 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 41 |
Why?
|
Hand | 2 | 1986 | 37 |
Why?
|
Frontal Lobe | 2 | 2001 | 33 |
Why?
|
Penicillins | 1 | 2005 | 35 |
Why?
|
Research | 1 | 2006 | 124 |
Why?
|
Adaptation, Psychological | 1 | 2006 | 110 |
Why?
|
Cognition Disorders | 1 | 2007 | 107 |
Why?
|
Activities of Daily Living | 1 | 2006 | 122 |
Why?
|
Cerebellar Nuclei | 1 | 2003 | 5 |
Why?
|
Cerebellar Ataxia | 1 | 2003 | 7 |
Why?
|
Dysarthria | 1 | 2003 | 4 |
Why?
|
Diagnostic Imaging | 1 | 2004 | 66 |
Why?
|
Societies, Medical | 1 | 2004 | 90 |
Why?
|
Walking | 1 | 2003 | 21 |
Why?
|
Cerebellum | 2 | 1986 | 59 |
Why?
|
Electrodes, Implanted | 1 | 2003 | 31 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 131 |
Why?
|
Aged, 80 and over | 3 | 2002 | 599 |
Why?
|
Methylphenidate | 1 | 2002 | 13 |
Why?
|
Clonidine | 1 | 2002 | 24 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2002 | 24 |
Why?
|
Vertebrates | 1 | 1981 | 14 |
Why?
|
Central Nervous System Stimulants | 1 | 2002 | 32 |
Why?
|
Double-Blind Method | 2 | 1998 | 274 |
Why?
|
Confidence Intervals | 1 | 2002 | 104 |
Why?
|
Electrodes | 1 | 2001 | 24 |
Why?
|
Motivation | 1 | 1983 | 85 |
Why?
|
Posture | 2 | 1995 | 68 |
Why?
|
Welding | 1 | 2001 | 4 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 195 |
Why?
|
Environment | 1 | 1981 | 43 |
Why?
|
Postoperative Complications | 2 | 1998 | 305 |
Why?
|
Time Factors | 3 | 2000 | 896 |
Why?
|
Prevalence | 1 | 2003 | 281 |
Why?
|
Single-Blind Method | 1 | 2000 | 86 |
Why?
|
Aggression | 1 | 1981 | 36 |
Why?
|
GABA Agonists | 1 | 1999 | 7 |
Why?
|
Occupational Diseases | 1 | 2001 | 51 |
Why?
|
Receptors, GABA-A | 1 | 1999 | 14 |
Why?
|
Epilepsies, Partial | 1 | 1999 | 11 |
Why?
|
Hippocampus | 2 | 1991 | 83 |
Why?
|
Mutation | 1 | 2005 | 340 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 1998 | 5 |
Why?
|
Pilot Projects | 1 | 2000 | 264 |
Why?
|
Electroencephalography | 1 | 1999 | 88 |
Why?
|
Mineral Oil | 1 | 1998 | 6 |
Why?
|
Sleep Apnea Syndromes | 1 | 1998 | 15 |
Why?
|
Phosphatidylcholines | 1 | 1998 | 28 |
Why?
|
Muscle Spasticity | 2 | 2003 | 14 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 114 |
Why?
|
Action Potentials | 2 | 1991 | 77 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 251 |
Why?
|
Reproducibility of Results | 2 | 2003 | 391 |
Why?
|
Kainic Acid | 1 | 1991 | 17 |
Why?
|
Rare Diseases | 1 | 2010 | 15 |
Why?
|
Rats | 3 | 1981 | 530 |
Why?
|
Pedunculopontine Tegmental Nucleus | 1 | 2008 | 1 |
Why?
|
Interdisciplinary Communication | 1 | 2008 | 26 |
Why?
|
Molecular Biology | 1 | 2008 | 38 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 47 |
Why?
|
Ataxia | 1 | 2006 | 17 |
Why?
|
Muscle Weakness | 1 | 2006 | 25 |
Why?
|
Clinical Protocols | 1 | 2007 | 93 |
Why?
|
Risk Factors | 2 | 2001 | 555 |
Why?
|
Macaca fascicularis | 1 | 2006 | 36 |
Why?
|
Muscle Spindles | 1 | 1986 | 4 |
Why?
|
Interview, Psychological | 1 | 2006 | 37 |
Why?
|
Macaca nemestrina | 1 | 2006 | 21 |
Why?
|
Organ Specificity | 1 | 2006 | 104 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2005 | 5 |
Why?
|
Sample Size | 1 | 2005 | 24 |
Why?
|
Brain Chemistry | 1 | 2006 | 60 |
Why?
|
Disability Evaluation | 1 | 2006 | 61 |
Why?
|
Cell Count | 1 | 2006 | 163 |
Why?
|
Stereotyped Behavior | 1 | 2005 | 13 |
Why?
|
Analysis of Variance | 1 | 2008 | 339 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 110 |
Why?
|
Exons | 1 | 2005 | 91 |
Why?
|
Psychometrics | 1 | 2006 | 97 |
Why?
|
Microinjections | 1 | 2005 | 30 |
Why?
|
Codon, Nonsense | 1 | 2005 | 15 |
Why?
|
Point Mutation | 1 | 2005 | 122 |
Why?
|
Survival Analysis | 1 | 2006 | 205 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 163 |
Why?
|
Efferent Pathways | 1 | 2003 | 13 |
Why?
|
Preoptic Area | 1 | 1983 | 6 |
Why?
|
Handling (Psychology) | 1 | 1983 | 3 |
Why?
|
Research Design | 1 | 2005 | 169 |
Why?
|
Sexual Behavior, Animal | 1 | 1983 | 6 |
Why?
|
Drinking | 1 | 1983 | 14 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 321 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 176 |
Why?
|
Orientation | 1 | 1983 | 29 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 431 |
Why?
|
Subtraction Technique | 1 | 2002 | 13 |
Why?
|
Fourier Analysis | 1 | 2002 | 23 |
Why?
|
Prospective Studies | 1 | 2007 | 545 |
Why?
|
Amphibians | 1 | 1981 | 4 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 257 |
Why?
|
Feeding Behavior | 1 | 1981 | 29 |
Why?
|
Mammals | 1 | 1981 | 47 |
Why?
|
Birds | 1 | 1981 | 17 |
Why?
|
Fishes | 1 | 1981 | 20 |
Why?
|
Neostriatum | 1 | 2001 | 20 |
Why?
|
Age of Onset | 1 | 2001 | 64 |
Why?
|
Species Specificity | 1 | 1981 | 186 |
Why?
|
Follow-Up Studies | 1 | 2006 | 553 |
Why?
|
Manganese | 1 | 2001 | 33 |
Why?
|
Thymoma | 1 | 1980 | 7 |
Why?
|
Thymus Neoplasms | 1 | 1980 | 12 |
Why?
|
Comorbidity | 1 | 2002 | 190 |
Why?
|
Rats, Inbred Strains | 1 | 1981 | 170 |
Why?
|
Myasthenia Gravis | 1 | 1980 | 18 |
Why?
|
Retrospective Studies | 1 | 2006 | 653 |
Why?
|
Occupational Exposure | 1 | 2001 | 53 |
Why?
|
Lubrication | 1 | 1998 | 2 |
Why?
|
Case-Control Studies | 1 | 2001 | 283 |
Why?
|
Surface Tension | 1 | 1998 | 15 |
Why?
|
Syndrome | 1 | 1998 | 142 |
Why?
|
Drug Combinations | 1 | 1998 | 95 |
Why?
|
Bronchi | 1 | 1998 | 45 |
Why?
|
Reference Values | 1 | 1998 | 278 |
Why?
|
Reflex, Stretch | 1 | 1986 | 3 |
Why?
|
Purkinje Cells | 1 | 1986 | 8 |
Why?
|
Haplorhini | 1 | 1986 | 43 |
Why?
|
Thymectomy | 1 | 1980 | 11 |
Why?
|
Receptors, Cholinergic | 1 | 1980 | 15 |
Why?
|
Acetylcholine | 1 | 1980 | 49 |
Why?
|
Tomography, X-Ray Computed | 1 | 1980 | 321 |
Why?
|
